D. Darmadi, T. Sungkar, C. Pakpahan, and S. S. Surja, “An Efficacy and Safety Comparison of Regorafenib and Nivolumab in Unresectable Hepatocellular Cancer Patients: A Systematic Review”, ama, vol. 53, no. 1, pp. 46–58, Apr. 2024.